COMMUNIQUÉS West-GlobeNewswire

INSYS Therapeutics to Report Fourth Quarter and Full Year 2018 Results on March 7

06/03/2019 - 22:15

PHOENIX, March 06, 2019 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced [...]

Nephros to Report Fourth Quarter and Year End 2018 Financial Results on March 12th, 2019

06/03/2019 - 22:15

SOUTH ORANGE, NJ, March 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, [...]

Xeris Pharmaceuticals Announces Fourth Quarter and Full Year 2018 Financial Results and Highlights Pipeline Progress

06/03/2019 - 22:10

Continuing to execute commercial build and launch readiness for Gvoke HypoPen™ Advancing pipeline of preclinical and clinical development-stage products Cash position of $112.6 million at year-end 2018; February 2019 [...]

Supernus to Present at the 2019 Cowen Health Care Conference

06/03/2019 - 22:10

ROCKVILLE, Md., March 06, 2019 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASADQ: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]

Adverum Biotechnologies Reports Fourth Quarter 2018 Financial Results and Provides Corporate Update

06/03/2019 - 22:10

Advancing Novel Gene Therapy ADVM-022 for Wet AMD in OPTIC Phase 1 Clinical Trial MENLO PARK, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy [...]

Portola Pharmaceuticals to Webcast Presentation at Cowen and Company’s 39th Annual Health Care Conference

06/03/2019 - 22:10

SOUTH SAN FRANCISCO, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today announced that Scott Garland, Portola’s president and chief executive officer, will present a [...]

Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock

06/03/2019 - 22:05

TUSTIN, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by [...]

Avinger Provides Fourth Quarter and Full Year 2018 Shareholder Update

06/03/2019 - 22:05

Pantheris Fourth Quarter Revenue Increases 18% Over Prior Quarter REDWOOD CITY, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company marketing the first and [...]

Teladoc Health to Participate in Upcoming Investor Conference

06/03/2019 - 22:05

PURCHASE, N.Y., March 06, 2019 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Jason Gorevic, chief executive officer, will participate in the following [...]

The Ensign Group Acquires Home Health and Hospice Operations in San Antonio, Texas

06/03/2019 - 22:05

MISSION VIEJO, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care, [...]

Dynavax to Present at 39th Annual Cowen Healthcare Conference

06/03/2019 - 22:05

BERKELEY, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering and developing novel vaccines and immuno-oncology [...]

SI-BONE, Inc. Announces Journal of Bone and Joint Surgery (JBJS) Publishes 2-Year Results from iMIA, a European Multicenter Randomized Controlled Trial (RCT) of SI Joint Fusion with iFuse Implant System® vs Conservative Care

06/03/2019 - 22:05

This is the 67th peer-reviewed iFuse publication and shows rapid and sustained improvements in pain, patient function and quality of life, consistent with INSITE, a U.S. RCT published in August, 2016 SANTA CLARA, Calif [...]

Kezar Life Sciences Announces Initiation of Clinical Study to Test a New Drug Product Formulation of KZR-616

06/03/2019 - 22:05

SOUTH SAN FRANCISCO, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet [...]

OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2018 Financial Results

06/03/2019 - 22:05

Record Full Year 2018 Revenue - Increase of 26.2% Year-Over-Year WARSAW, Indiana, March 06, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric [...]

Assertio Therapeutics Announces Fourth-Quarter and Full-Year 2018 Financial Results

06/03/2019 - 22:02

-- Reports Neurology Franchise Annual Net Sales of $110.3 million, at the High End of Guidance Range -- -- Files NDA for Long-Acting Cosyntropin and Receives FDA Notification of Acceptance -- -- Issues Full-Year 2019 [...]

Entasis Therapeutics to Present at the 39th Annual Cowen Healthcare Conference

06/03/2019 - 22:01

WALTHAM, Mass., March 06, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, [...]

Selecta Biosciences to Present at the Cowen Annual Health Care Conference March 13, 2019

06/03/2019 - 22:01

WATERTOWN, Mass., March 06, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB) (“Selecta”), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on [...]

CareDx Reports Fourth Quarter and FY 2018 Results

06/03/2019 - 22:01

AlloSure launch momentum drives 88% fourth quarter revenue growth BRISBANE, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA), a molecular diagnostics company focused on the discovery, development [...]

Xenon Pharmaceuticals Reports 2018 Financial Results and Provides Corporate Update

06/03/2019 - 22:01

Multiple Neurology-Focused Products Anticipated to be in Phase 2 or Later Stage Development in 2019 Global XEN1101 Phase 2b Clinical Trial Underway with Data Anticipated in Second Half of 2020 Conference Call at 4:30 pm [...]